// company-profile
Intellia Therapeutics, Inc. Insider Trading
NTLAEvery SEC Form 4 insider trading filing for Intellia Therapeutics, Inc. (NTLA) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=NTLA" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $91K across 1 transaction.
// 90-day insight
Over the last 90 days, Intellia Therapeutics, Inc. insiders bought $0 (14 transactions) and sold $136K (2 transactions).
- Most active insider: Dulac Edward J III with 2 transactions totaling $175K.
- Largest single sale: $91K by Dulac Edward J III on Jul 22, 2026.
- 33% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Intellia Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | Dulac Edward J III | NTLA | Sale | 8,111 | $11.25 | $91K |
| Jul 2, 2026 | Dulac Edward J III | NTLA | Sale10b5 | 4,677 | $18.00 | $84K |
| Jul 1, 2026 | Dube Michael P | NTLA | Sale | 2,641 | $16.78 | $44K |
| Jun 9, 2026 | Cohen Fred E | NTLA | Award | 9,200 | $0.00 | $0K |
| Jun 9, 2026 | Goff Brian | NTLA | Award | 9,200 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →